Valproale induces hyperglycinuria (6-8) and hyperammonemia (4) in children. Its experimental use in rats to obtain a propionic acidemia model was proposed (8) because propionic acid is known to accumulate probably as an intermediary metabolite in valproate-treated patients. In the search of the mechanism by which propionate inhibits ureagenesis (1, 3, 10) and because of the analogy between some toxic effects of valproate and the ketotic hyperglycinemia syndrome (hyperglycinuria, leucopenia and thrombocytopenia), we have studied the in vivo metabolic effects of valproate on the mitochondrial steps of ureagenesis in rat.
Valproale induces hyperglycinuria (6) (7) (8) and hyperammonemia (4) in children. Its experimental use in rats to obtain a propionic acidemia model was proposed (8) because propionic acid is known to accumulate probably as an intermediary metabolite in valproate-treated patients. In the search of the mechanism by which propionate inhibits ureagenesis (1, 3, 10) and because of the analogy between some toxic effects of valproate and the ketotic hyperglycinemia syndrome (hyperglycinuria, leucopenia and thrombocytopenia), we have studied the in vivo metabolic effects of valproate on the mitochondrial steps of ureagenesis in rat.
Rats were killed 2 hr after intraperitoneal injection of sodium valproate (100 mg/kg). Mitochondria were prepared immediately from livers (5) . In valproate-treated rats, we observed (Table 1 ) a have shown previously (10) indicates that NAGA must be the key factor. The addition of ATP increases the citrullinogenesis in both groups, but it remains significantly lower in valproate-treated patients. This implies that when ATP freely enters the mitochondria and is not any more a rate-limiting factor, the citrullinogenesis is limited by the NAGA level. This valproate effect is analogous to the effect of propionate which we have observed in intact mitochondria (I, 10). Nevertheless, the intraperitoneal injection of propionate at the same levels in rat does not decrease the citrullinogenesis (2). Therefore, propionyl-CoA does not seem to be responsible for the valproate inhibition and valproyl CoA or some closely related compounds must be the effective inhibitor. We are proposing that the valproate-induced hyperammonemia is second- I citrullinogenesis, NAGA level, NAGA synthetase, CPS-1, and ornithine transcarbamylase are measured in isolated mitochondria as previously described (3, 4, 6) .
* CIT, citrullinogenesis.
W e a n + S.D.
NS, not significant. highly significant inhibition of citrullinogenesis in the presence of ary to an inhibition of the mitochondrial NAGA synthesis. In this succinate but not in the presence of glutamate. In the presence of way, N-carbamyl-glutamate which seems to cross freely the bio-ATP, oligomycin, and 2,4-dinitrophenol, the citrullinogenesis was logic membranes and activates CPS-1 (9) might be useful in the increased, but there was always a significant inhibition in valmanagement of patients with these valproate adverse effects. proate-treated rats. Concomitantly, there was a significant decrease of mitochondria1 N -acetylglutarnate (NAGA) level in val-
